Social investing and trading platform

IPO NASDAQ: ETOR (2025)

Mobility app for real-time public transit

Acquired by Intel in May 2020

AI cybersecurity platform for SMBs

Advanced AI reasoning and superintelligence

AI-based digital health platform & HMO

AI-driven private credit platform

Via Meitav

Transcatheter solutions for heart valve disease

Autonomous drone delivery

Non-invasive fluid removal through skin

Together since 2010

Leading investment house in Israel, managing over 77 Billion Dollars for private, business and institutional clients

Advanced devices for stroke treatment

Implantable device to treat congestive heart failure

Acquired by J&J in October 2024

Degania Silicone Announces the Acquisition of Controlling Interest in Biometrix

Degania Silicone Ltd., a leading OEM manufacturer of silicone products for the medical device industry, announced today that has reached an agreement to acquire a controlling interest in Biometrix Ltd., a privately-owned, Jerusalem based, leading developer, manufacturer and marketer of medical devices for use in operating rooms, ICUs and interventional cardiology procedures. The acquisition is expected to close in the coming weeks. Along with its acquisition of Arthesys SAS (Paris, France) in 2010, this transaction represents further execution upon Degania’s strategic plan to create a strong worldwide player specializing in the development and supply of Indwelling Medical Catheters and other specialized medical devices to the health care industry.

By joining forces with Degania, Biometrix will be able to offer expanded product lines and more complete solutions to its customers worldwide. Mr. Yair Mendels, founder of Biometrix, will continue to serve in his capacity as chief executive officer and director of product development at Biometrix.